Please Note:
This profile was automatically generated using 81 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 81 references found on the Internet. This information has not been verified. Learn more...
View all 81 references Web References
-
1. www.fiercebiotech.com
www.fiercebiotech.com/tags/cel - [Cached]Published on: 10/30/2007 Last Visited: 10/30/2007
Celgene has named Thomas Daniel to the new position of president of Celgene research. -
2. PRESS RELEASE: Array BioPharma and Celgene in $40 Million Cancer, Inflammation Deal - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News
www.fiercebiotech.com/press-re - [Cached]Published on: 10/30/2007 Last Visited: 1/30/2008
Our collaboration illustrates Celgene's commitment to address unmet medical need in cancer and immune-inflammatory disease, while maximizing our clinical, regulatory and commercial potential worldwide," said Tom Daniel, M.D., President of Research, Celgene Corporation. -
3. CHI, Cambridge Healthtech Institute
ww.healthtech.com/2005/pgd/ind - [Cached]Published on: 1/1/2005 Last Visited: 8/1/2007
Dr. Thomas O. Daniel, Chief Scientific Officer, Ambrx, Inc.
